PubRank

G G Jackson

Author PubWeight™ 95.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Activity of aminoglycoside antibiotics aganst Pseudomonas aeruginosa: specificity and site of calcium and magnesium antagonism. J Infect Dis 1973 3.67
2 Pharmacology of gentamicin in man. J Infect Dis 1971 3.16
3 Current therapeutics. 234. Gentamicin. Practitioner 1967 2.54
4 Laboratory and clinical conditions for gentamicin inactivation by carbenicillin. Arch Intern Med 1972 2.19
5 Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation. J Infect Dis 1990 2.11
6 A new subunit influenza vaccine: acceptability compared with standard vaccines and effect of dose on antigenicity. J Infect Dis 1972 2.06
7 Ototoxicity of gentamicin in man: a survey and controlled analysis of clinical experience in the United States. J Infect Dis 1971 1.97
8 Pseudomonas bacteremia: pharmacologic and other bases for failure of treatment with gentamicin. J Infect Dis 1971 1.89
9 An evaluation of the use of statistical methodology in the Journal of Infectious Diseases. J Infect Dis 1984 1.82
10 Alterations in outer membrane proteins of Pseudomonas aeruginosa associated with selective resistance to quinolones. Antimicrob Agents Chemother 1988 1.70
11 Viremia in Asian influenza. Trans Assoc Am Physicians 1966 1.70
12 Humoral and cellular response in humans after immunization with influenza vaccine. Infect Immun 1973 1.54
13 Antibacterial activity of cinoxacin in vitro. Antimicrob Agents Chemother 1975 1.50
14 Effect of isoprinosine against influenza and some other viruses causing respiratory diseases. Antimicrob Agents Chemother 1972 1.48
15 Comparative in vitro activity of azlocillin, ampicillin, mezlocillin, piperacillin, and ticarcillin, alone and in combination with an aminoglycoside. Antimicrob Agents Chemother 1979 1.47
16 Acute respiratory illness among immunized and nonimmunized patients with high-risk factors during a split season of influenza A and B. J Infect Dis 1988 1.46
17 Neutralizing activity in nasal secretions and serum in resistance of volunteers to parainfluenza virus type 2. J Immunol 1968 1.42
18 First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use. Antimicrob Agents Chemother 1991 1.40
19 Observations of the staphylococcal nasal carrier state. Ann N Y Acad Sci 1965 1.34
20 Production of interferon in volunteers infected with Asian influenza. J Infect Dis 1970 1.33
21 Increased virus shedding with aspirin treatment of rhinovirus infection. JAMA 1975 1.31
22 Netilmicin: clinical efficacy, tolerance, and toxicity. Antimicrob Agents Chemother 1978 1.29
23 Prevention of illness from rhinovirus infection by a topical interferon inducer. N Engl J Med 1974 1.27
24 High-pressure liquid chromatographic assay of netilmicin in plasma. Antimicrob Agents Chemother 1977 1.21
25 Viruses causing common respiratory infection in man. IV. Reoviruses and Adenoviruses. J Infect Dis 1973 1.17
26 Use and withdrawal of amantadine chemoprophylaxis during epidemic influenza A. Am Rev Respir Dis 1976 1.15
27 Viremia with herpes simplex type 1 in adults. Four nonfatal cases, one with features of chicken pox. Ann Intern Med 1976 1.15
28 Prospective study of prevalence, incidence, and source of herpesvirus infections in patients with renal allografts. J Infect Dis 1977 1.14
29 Antiviral agents in influenza--summary of Influenza Workshop VIII. J Infect Dis 1976 1.12
30 Attitudes and behavior of health care personnel regarding the use and efficacy of influenza vaccine. J Infect Dis 1985 1.10
31 Viruses causing common respiratory infections in man. J Infect Dis 1973 1.08
32 The limited effect of nasal interferon induced by rhinovirus and a topical chemical inducer on the course of infection. J Infect Dis 1973 1.05
33 Acute-phase decrease of T lymphocyte subsets in rhinovirus infection. J Infect Dis 1986 1.04
34 Prevention and control of influenza by chemoprophylaxis and chemotherapy. Prospects from examination of recent experience. JAMA 1976 1.02
35 Methods for the clinical evaluation of antibiotics in urinary tract infections. Scand J Infect Dis Suppl 1978 1.02
36 Efficacy of cinoxacin in urinary tract infections. Antimicrob Agents Chemother 1976 1.01
37 Herpes virus latency in spinal ganglia of mice without illness. Proc Soc Exp Biol Med 1974 1.00
38 Protection with split and whole virus vaccines against influenza. Arch Intern Med 1973 0.99
39 Biphasic, concentration-dependent and rate-limited, concentration-independent bacterial killing by an aminoglycoside antibiotic. J Infect Dis 1984 0.98
40 Topical enviroxime against rhinovirus infection. Antimicrob Agents Chemother 1982 0.97
41 Fungal and mycobacterial infections in patients infected with the human immunodeficiency virus. J Antimicrob Chemother 1989 0.97
42 Study of delayed hypersensitivity to myxoviruses induced by vaccines. Appl Microbiol 1969 0.94
43 Prevention of herpesvirus infections in renal allograft recipients by low-dose oral acyclovir. JAMA 1985 0.91
44 Nasal-secretion leukocyte populations determined by flow cytometry during acute rhinovirus infection. J Med Virol 1988 0.91
45 Infectious Diseases Society of America. Trials of interferon therapy for multiple sclerosis. J Infect Dis 1982 0.91
46 Sequence analysis of an HIV-1 isolate which displays unusually high-level AZT resistance in vitro. J Med Virol 1992 0.90
47 From the Infectious Diseases Society of America. Hospital epidemiology and infection control: the changing role of the specialist in infectious diseases. J Infect Dis 1981 0.89
48 Viruses causing common respiratory infections in man. V. influenza A (Asian). J Infect Dis 1975 0.89
49 Gentamicin plus carbenicillin. Lancet 1971 0.89
50 Search for latent cytomegalovirus in renal allografts. Infect Immun 1978 0.89
51 Experimental pseudomonas osteomyelitis: treatment with sisomicin and carbenicillin. J Bone Joint Surg Am 1974 0.87
52 Long-term oral ciprofloxacin: experience in the treatment of incurable infective endocarditis. Am J Med 1988 0.87
53 Intravenous and intraocular ganciclovir for CMV retinitis in patients with AIDS or chemotherapeutic immunosuppression. Br J Ophthalmol 1988 0.87
54 Viruses causing common respiratory infections in man. 3. Respiratory syncytial viruses and coronaviruses. J Infect Dis 1973 0.87
55 Sensitivity of influenza A virus to amantadine. J Infect Dis 1977 0.84
56 In vitro and clinical effects of cephaloridine: a semisynthetic antibiotic. Am J Med Sci 1967 0.83
57 Live and killed adenovirus vaccines for the prevention of acute respiratory disease in recruits. Antimicrob Agents Chemother (Bethesda) 1965 0.83
58 Perspective from a quarter century of antibiotic usage. JAMA 1974 0.83
59 Clinical manifestations of infections with herpesviruses after kidney transplantation: a prospective study of various syndromes. Ann Surg 1978 0.83
60 Assay of aminoglycoside antibiotics in clinical specimens. J Infect Dis 1975 0.83
61 Isolation of Mycoplasma pneumoniae from adults with respiratory infections. Arch Intern Med 1966 0.82
62 Stress and sugar control in children with insulin-dependent diabetes mellitus. J Pediatr 1981 0.82
63 Spread of enteric live adenovirus type 4 vaccine in married couples. J Infect Dis 1969 0.81
64 Dual respiratory infection with parainfluenza and rhinovirus. The pathogenesis of transmitted infection in volunteers. Am Rev Respir Dis 1966 0.81
65 Communicability of enteric live adenovirus type 4 vaccine in families. J Infect Dis 1969 0.81
66 Effect of a topical interferon inducer on rhinovirus infections in volunteers. J Infect Dis 1976 0.81
67 Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora. Am J Med 1987 0.80
68 Oral ribavirin treatment of influenza A and B. Antimicrob Agents Chemother 1987 0.80
69 Comparative activity of bacterial beta-lactamases on penicillins and cephalosporins. J Infect Dis 1973 0.80
70 Actinobacillus actinomycetemcomitans endocarditis in a patient with a prosthetic aortic valve. Infection 1977 0.80
71 Increasing experience for the evaluation of antiviral chemotherapy. J Infect Dis 1980 0.79
72 Oxolinic acid treatment of urinary-tract infections. Antimicrob Agents Chemother (Bethesda) 1967 0.79
73 Characteristics of vaccine-induced and natural infection with adenovirus type 4 in naval recruits. Am J Epidemiol 1968 0.78
74 Live and inactivated adenovirus vaccines for the prevention of acute respiratory illness in naval recruits. Am J Epidemiol 1968 0.77
75 Mass enteric live adenovirus vaccination during epidemic ARD. JAMA 1968 0.77
76 A perspective from controlled investigations of chemotherapy for viral respiratory infections. J Infect Dis 1976 0.76
77 The key role of aminoglycosides in antibacterial therapy and prophylaxis. J Antimicrob Chemother 1984 0.76
78 Clinical assessment of newer antibiotics. Effect in compromised hosts and drug combinations. Scand J Infect Dis Suppl 1980 0.76
79 Influence of adrenocorticotropin and adrenalectomy on gonadotropin secretion in immature rats. Neuroendocrinology 1982 0.76
80 ECHO-11 as a respiratory virus: quantitation of infection in man. J Clin Invest 1968 0.75
81 A new subunit influenza vaccine; acceptability compared with standard vaccines and antigenicity in increasing dosage. Postgrad Med J 1973 0.75
82 Double-blind comparison of cephacetrile with cephalothin-cephaloridine. Antimicrob Agents Chemother 1974 0.75
83 Is behavior therapy a threat to black clients? J Natl Med Assoc 1976 0.75
84 Antiviral chemotherapy--a frontier for health and learning. Yale J Biol Med 1983 0.75
85 The new DRGs -- opportunity for medical record professionals. J Am Med Rec Assoc 1982 0.75
86 Effects of water and furosemide-induced diuresis on the acquisition and course of experimental pyelonephritis. J Lab Clin Med 1971 0.75
87 Antibody response in rabbits to antigenic stimulation during amantadine treatment. Proc Soc Exp Biol Med 1967 0.75
88 Dependence of the interaction of ceftazidime and gentamicin against Pseudomonas aeruginosa on the bacterial growth-rate. J Antimicrob Chemother 1991 0.75
89 Serologic response in man to adenovirus and SV40 components in adenovirus vaccines. Proc Soc Exp Biol Med 1967 0.75
90 Comparative in vitro activity of Bay k 4999 and piperacillin. J Antimicrob Chemother 1979 0.75
91 Nonbacterial pneumonias: contributions of Maxwell Finland revisited. J Infect Dis 1972 0.75
92 Utilization reporting system facilitates physician practice analysis. J Ambul Care Manage 1985 0.75
93 Therapy with combinations of penicillin analogues in urinary-tract infections. Antimicrob Agents Chemother (Bethesda) 1969 0.75
94 Infectious diseases 1979--an editorial perspective. J Infect Dis 1979 0.75
95 A new generation of beta-lactam antibiotics: anticipating future developments and needs. Rev Infect Dis 1983 0.75
96 Self-administered histories let doctor concentrate on patient. Mod Hosp 1971 0.75
97 The pathogenesis and treatment of pyelonephritis. Int Z Klin Pharmakol Ther Toxikol 1968 0.75
98 Letters to the Editor. Am J Public Health Nations Health 1959 0.75
99 Viruses causing common respiratory infections in man. II. Enteroviruses and paramyxoviruses. J Infect Dis 1973 0.75
100 Experience with vaccines--summary. Natl Cancer Inst Monogr 1968 0.75
101 Considerations of antibiotic prophylaxis in nonsurgical high risk patients. Am J Med 1981 0.75
102 The evaluation of antiviral drugs in volunteers. Prog Med Virol 1968 0.75
103 Edward H. Kass--more than the editor. J Infect Dis 1978 0.75
104 Detection, prevention and control of hospital-acquired infections. Infection 1978 0.75
105 The clinical versatility of aminoglycosides. J Antimicrob Chemother 1984 0.75
106 [Prophylactic use of antibiotics (author's transl)]. MMW Munch Med Wochenschr 1979 0.75
107 A tool for quick and easy data collection. MCN Am J Matern Child Nurs 1985 0.75
108 Sleeping dragon in hospitals. Health Care Week 1978 0.75
109 Diagnosis and importance of asymptomatic bacteriuria in adults. Infection 1975 0.75
110 Antibiotic policies, practices and pressures. J Antimicrob Chemother 1979 0.75
111 Cephaloridine treatment of bacterial infections. Antimicrob Agents Chemother (Bethesda) 1965 0.75
112 Infectious Diseases Society of America. Concepts in training, performance in practice. J Infect Dis 1975 0.75
113 The new DRGs -- ICD-9-CM. J Am Med Rec Assoc 1982 0.75
114 Control of acute viral respiratory diseases. Effects of infection, vaccines, and chemotherapy. Arch Environ Health 1967 0.75
115 Introduction of gentamicin. Laboratory and clinical trials. G Ital Chemioter 1971 0.75